 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, September 1, 2002, 22(17):7596-7605
Heterotopic Neurons with Altered Inhibitory Synaptic Function in an Animal Model of Malformation-Associated Epilepsy
Maria Elisa Calcagnotto, Mercedes F. Paredes, and Scott C. Baraban Epilepsy Research Laboratory, Department of Neurological Surgery and The Graduate Program in Neuroscience, University of California, San Francisco, San Francisco, California 94143
Children with brain malformations often exhibit an intractable form of epilepsy. Although alterations in cellular physiology and abnormal histology associated with brain malformations has been studied extensively, synaptic function in malformed brain regions remains poorly understood. We used an animal model, rats exposed to methylazoxymethanol (MAM) in utero, featuring loss of lamination and distinct nodular heterotopia to examine inhibitory synaptic function in the malformed brain. Previous in vitro and in vivo studies demonstrated an enhanced susceptibility to seizure activity and neuronal hyperexcitability in these animals. Here we demonstrate that inhibitory synaptic function is enhanced in rats exposed to MAM in utero. Using in vitro hippocampal slices and whole-cell voltage-clamp recordings from visualized neurons, we observed a dramatic prolongation of GABAergic IPSCs onto heterotopic neurons. Spontaneous IPSC decay time constants were increased by 195% and evoked IPSC decay time constants by 220% compared with age-matched control CA1 pyramidal cells; no change in IPSC amplitude or rise time was observed. GABA transport inhibitors (tiagabine and NO-711) prolonged evoked IPSC decay kinetics of control CA1 pyramidal cells (or normotopic cells) but had no effect on heterotopic neurons. Immunohistochemical staining for GABA transporters (GAT-1 and GAT-3) revealed a low level of expression in heterotopic cell regions, suggesting a reduced ability for GABA reuptake at these synapses. Together, our data demonstrate that GABA-mediated synaptic function at heterotopic synapses is altered and suggests that inhibitory systems are enhanced in the malformed brain.
Key words: dysplasia; epilepsy; heterotopia; inhibition; GAT; patch clamp
Copyright © 2002 Society for Neuroscience 0270-6474/02/22177596-10$05.00/0
This article has been cited by other articles:
D. L. Jones and S. C. Baraban
Characterization of Inhibitory Circuits in the Malformed Hippocampus of Lis1 Mutant Mice
J Neurophysiol, November 1, 2007; 98(5): 2737 - 2746.
[Abstract] [Full Text] [PDF]
S. A. Trotter, J. Kapur, M. J. Anzivino, and K. S. Lee
GABAergic Synaptic Inhibition Is Reduced before Seizure Onset in a Genetic Model of Cortical Malformation.
J. Neurosci., October 18, 2006; 26(42): 10756 - 10767.
[Abstract] [Full Text] [PDF]
H. Xiang, H.-X. Chen, X.-X. Yu, M. A. King, and S. N. Roper
Reduced Excitatory Drive in Interneurons in an Animal Model of Cortical Dysplasia
J Neurophysiol, August 1, 2006; 96(2): 569 - 578.
[Abstract] [Full Text] [PDF]
M. Alvarez-Dolado, M. E. Calcagnotto, K. M. Karkar, D. G. Southwell, D. M. Jones-Davis, R. C. Estrada, J. L. R. Rubenstein, A. Alvarez-Buylla, and S. C. Baraban
Cortical inhibition modified by embryonic neural precursors grafted into the postnatal brain.
J. Neurosci., July 12, 2006; 26(28): 7380 - 7389.
[Abstract] [Full Text] [PDF]
E. Kobayashi, A. P. Bagshaw, C. Grova, J. Gotman, and F. Dubeau
Grey matter heterotopia: what EEG-fMRI can tell us about epileptogenicity of neuronal migration disorders
Brain, February 1, 2006; 129(2): 366 - 374.
[Abstract] [Full Text] [PDF]
M. E. Calcagnotto, M. F. Paredes, T. Tihan, N. M. Barbaro, and S. C. Baraban
Dysfunction of Synaptic Inhibition in Epilepsy Associated with Focal Cortical Dysplasia
J. Neurosci., October 19, 2005; 25(42): 9649 - 9657.
[Abstract] [Full Text] [PDF]
S. Keros and J. J. Hablitz
Subtype-Specific GABA Transporter Antagonists Synergistically Modulate Phasic and Tonic GABAA Conductances in Rat Neocortex
J Neurophysiol, September 1, 2005; 94(3): 2073 - 2085.
[Abstract] [Full Text] [PDF]
A. Galvan, R. M. Villalba, S. M. West, N. T. Maidment, L. C. Ackerson, Y. Smith, and T. Wichmann
GABAergic Modulation of the Activity of Globus Pallidus Neurons in Primates: In Vivo Analysis of the Functions of GABA Receptors and GABA Transporters
J Neurophysiol, August 1, 2005; 94(2): 990 - 1000.
[Abstract] [Full Text] [PDF]
M. E. Calcagnotto and S. C. Baraban
Prolonged NMDA-Mediated Responses, Altered Ifenprodil Sensitivity, and Epileptiform-Like Events in the Malformed Hippocampus of Methylazoxymethanol Exposed Rats
J Neurophysiol, July 1, 2005; 94(1): 153 - 162.
[Abstract] [Full Text] [PDF]
A. Barberis, C. Lu, S. Vicini, and J. W. Mozrzymas
Developmental Changes of GABA Synaptic Transient in Cerebellar Granule Cells
Mol. Pharmacol., April 1, 2005; 67(4): 1221 - 1228.
[Abstract] [Full Text] [PDF]
Y. Aghakhani, D. Kinay, J. Gotman, L. Soualmi, F. Andermann, A. Olivier, and F. Dubeau
The role of periventricular nodular heterotopia in epileptogenesis
Brain, March 1, 2005; 128(3): 641 - 651.
[Abstract] [Full Text] [PDF]
G. Battaglia, S. Pagliardini, L. Saglietti, F. Cattabeni, M. Di Luca, S. Bassanini, and V. Setola
Neurogenesis in Cerebral Heterotopia Induced in Rats by Prenatal Methylazoxymethanol Treatment
Cereb Cortex, July 1, 2003; 13(7): 736 - 748.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|